Close
ACHEMA MIDDLE EAST 2026

Biology-Driven AI Pushing Drug Discovery To Bigger Levels

The painstaking journey to bring one new drug to market almost spans a decade and costs an average of $2.6 billion. The AI as...

Analytical Laboratory Instruments Eying Record High By 2028

As per the latest BCC Research study, demand for Analytical Laboratory Instruments Manufacturing: Global Markets is all set to increase from $60.9 billion in...

Lab Automation & Digital Shift To Enhance SDG 2030 Agenda

The UN 2030 Agenda of the Sustainable Development Goals goes on to cover the economic, social, as well as environmental dimensions when it comes...

Lab Connectivity – Way Forward To Data-Driven Discoveries

Technology has gone on to change almost every aspect when it comes to the daily lives and has swiftly redefined the way one manages...

Big Pharma Plan Spending 7% Revenue On Next-Gen Labs By 2025

Pharmaceutical organizations happen to be rethinking their approach when it comes to the setup and operations of their labs, with an emphasis on speeding...

Data Intelligence Is The Key To Turning Lab Outcomes Better

With the advancement when it comes to automation and new drug modalities, modern labs happen to generate more data than ever; however, turning data...

Digital Innovation In Therapeutics For Faster Market Access

Right from finding potential active substances as well as identifying novel targets to simulating how drugs will perform within the human body and also...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...